Uncategorized

AML3D (ASX:AL3) has received a $2M order from US Navy for submarine parts. In response, interim CEO Sean Ebert said: “AML3D’s focus is on the US defence, aviation and maritime sectors and the company is well positioned to access the many opportunities that will be created as a result of the AUKUS Alliance, in the […]

China’s shift towards deflation is causing concern in financial markets, yet some money managers suggest potential positive outcomes, as lower prices stemming from China’s role as a major global producer could lead to reduced costs worldwide. This deflationary trend might enable central banks to avoid further interest rate hikes, potentially pivoting towards easing to support

Investing in infrastructure can deliver downside protection, inflation protection and diversification. Tim Humphreys, Head of Global Listed Infrastructure at Ausbil Investment Management, discusses the asset class and opportunities in the short and medium term. Paul Sanger: Hi. I’m Paul Sanger from the Finance News Network, and today we’re interviewing Tim Humphreys, who is the Portfolio

Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.

Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.

Nicholas Pollock – CEO – K2fly (ASX:K2F) delivers resource governance software and services to Tier 1 clients working in the asset-intensive sectors of mining, utilities, oil and gas, and rail.

Brad Gurrie – CEO – Socialsuite is a global Software-as-a-Service (SaaS) enterprise, leading the industry in offering solutions for Environmental, Social, and Governance reporting and outcomes measurement.

Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.

Yoav Amitai – CEO – Elsight’s (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.